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 Abstract: The researches continue the observations on the experimental diabetes induced with 
Streptozotocin in rat. In the induced diabetes there were observed infiltrative lesions of oedema type in the retina, 
oedema of the cilliary processes, predominant neutrophilic infiltrate into the lens. In the control group (healthy) 
and in the groups with induced diabetes, treated for a period of two months with ERIDIAROM® and with 
DIAVIT (original phytotherapeutic products) the changes were of little intensity and without morphopathological 
relevance. 
 
MATERIAL AND METHODS 
 
 The researches were made on Wistar male rats, with the average body weight of 150 g, 
in which the diabetes was induced by i.p. administration of 4mg/100g body weight 
Streptozotocin. After 3 days, there were formed 5 groups of 6 animals / each and another 
group of 6 healthy animals (healthy control group). All the animals were kept and fed in 
standardized conditions. 
 The groups were divided as follow: 
Group 1 - healthy control group; 
Group 2 – it was not treated after the induction of the diabetes – diabetic control group; 
Group 3 - -treated with 2.7 g ERIDIAROM® per day (9 tablets); 
Group 4 – treated with 3 g of DIAVIT per day (3 tablets); 
Group 5 – treated with 0.850 g of SIOFOR (1 tablet) together with 2 g of lactose; 
Group 6 – treated with 2 g of MEGUAN (4 tablets of 500 mg) together with 2 g of lactose. 
 The observation and the treatment were for a period of 60 days, after there were 
prelevated organs samples for the histopathological exams). The pieces were fixed, sectioned 















                                                                           
Fig.1 Retina – group 1- healthy control group        Fig. 2. Retina - group 2 - diabetic control  
(Trichromic stained X 400)  group – generalized diffuse edema 
(Trichromic stained X 400) 
 
 
                                                                  
Fig. 3. Retina -  group 2 - diabetic       Fig.4. Retina – group 2 - diabetic control  
control group – edema and dilaceration                                  group – monocytic perivascularity 
at the external plexiform layer                      in the internal limitant   
(Trichromic stained X 400)        (Trichromic stained X 100) 
 
                                                          
Fig.5. Retina – group 3 - treated               Fig.6. Retina – group 4 - treated 
with ERIDIAROM®                                                        with DIAVIT                         
(Trichromic stained X 100)               (Trichromic stained X 100) 
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Fig.7. Ciliary process                   Fig.8.    Ciliary process  
– group 1 - healthy control group              – group 2 - diabetic control group 
(Trichromic stained X 200)              - edema and hyperplasia in the basal 
                                    layer and epithelial hyperplasia 
                    (Hematoxylin - Eosin stained X 100) 
 
                                                                            
Fig.9. Ciliary process - group 3                             Fig.10. Ciliary process - group 4       
- treated with ERIDIAROM®  - treated with DIAVIT 
(Hematoxylin - Eosin stained X 200)                                 (Hematoxylin - Eosin stained X 200) 
 
                                                                           
Fig.11. Lens - group 1-                                      Fig.12.   Lens - group 2 -    
 healthy control group                                                               diabetic control group – 
(Hematoxylin - Eosin stained X 200)                                               neutrophilic infiltration in focus 
                   (Trichromic stained X 100) 
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Fig.13. Lens - group 2 -                              Fig.14. Lens - group 3 -      
diabetic control group –                           treated with ERIDIAROM® 
neutrophilic infiltration with              (Hematoxylin - Eosin stained X 100) 
lysis and dilaceration 
(Hematoxylin - Eosin stained X 100) 
 
                  
Fig.15.  Lens - group 4 –  
treated with DIAVIT  




 Examining the eye-bowl lesions in retina, lens and ciliary process, we have noticed 
large oedemas and infiltrations in lens. 
 We consider that the treatment has to reduce the oedema by the remake of the 
elasticity and permeability of capillary vessels, which are capable to “drain” the extravasate 
liquids into the organ. 
 The diabetic retinopatia is oedematosa and not proliferative, this is the reason why 
after the disappearance of the oedema the retina becomes functional.   
 The termo-cauterization of the fragile broken capillary, beside that aggravates the 
oedema, it also block the draining, making difficult the amelioration of the lesions. 
 The replacing of the infiltrative neutrofilic lens does not solve the problem, because 
this manoeuvre itself aggravate the oedema and the retina being oedematosa remain 
unreceptive.  
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 We have experimentally demonstrated that the infiltrative lesions in lens are “retract 
themselves” after two, three months of treatment with ERIDIAROM® and DIAVIT and the 
lens becomes functional. 
 The observed lesions in the eye-bowl of the animals with experimental diabetes make 




• After the induced diabetes with Streptozotocin we notice at retina level generalized 
diffuse oedema, dilaceration at the external plexiform layer and in the internal limitant 
monocityc perivascularity. 
• At the ciliary process it was noticed epithelial hyperplasia and oedema in the basal layer. 
• At the lens level it is a neutrophilic infiltration in focus with the lysis and dilaceration of 
the organ. 
• In control group and in the groups treated for a period of 60 days after the diabetes 
induction, with ERIDIAROM® and DIAVIT (original phytotherapeutical products) the 
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